US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

MiNK Therapeutics, Inc.

23.11

-4.9000-17.49%

Post-market: 24.401.29+5.58%19:29 EDT

Volume:883.53K

Turnover:23.83M

Market Cap:92.11M

PE:-9.25

High:30.64

Open:28.43

Low:23.11

Close:28.01

Loading ...

Overview Company News Filings

BRIEF-Mink Therapeutics Announces Publication Of Complete Remission

Mink Therapeutics Announces Promising Results of Allogeneic iNKT Cell Therapy, Achieving Complete Remission in Metastatic Testicular Cancer

Mink Therapeutics Announces Publication of Complete Remission Following Allogeneic Inkt Cell Therapy in Metastatic Testicular Cancer

THOMSON REUTERS

MiNK Therapeutics Holds Annual Stockholders Meeting

Mink Therapeutics Inc. Conducted Annual Stockholders Meeting

Press Release: MiNK Therapeutics Announces Virtual Annual Shareholders Meeting

MiNK Therapeutics Secures NIAID Grant to Advance Allo-iNKT Cell Therapy for GvHD Prevention in Collaboration with University of Wisconsin

Mink Therapeutics Awarded Prestigious Niaid Grant to Advance Allo-Inkt Cell Therapy for Prevention of Gvhd in Stem Cell Transplant Patients

THOMSON REUTERS

MiNK Therapeutics: Promising Clinical Trials and Strategic Plans Justify Buy Rating

Mink Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

MiNK Therapeutics Q1 EPS $(0.70) Beats $(0.71) Estimate

MiNK Therapeutics Reports Q1 2025 Results: Net Loss Decreases to $2.8 Million, EPS Improves to $(0.70)

Mink Therapeutics Reports Q1 2025 Results and Highlights Clinical & Strategic Progress

THOMSON REUTERS

Press Release: MiNK Therapeutics Reports Q1 2025 Results and Highlights Clinical & Strategic Progress

MiNK Therapeutics to Provide Corporate Update and First Quarter 2025 Financial Report

MiNK Therapeutics Inc (INKT) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...

MiNK Therapeutics Reports 2024 Progress and Financials

Q4 2024 Mink Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents

Buy Rating Affirmed for MiNK Therapeutics Amid Promising Clinical Developments and Strategic Expansion

Promising Clinical Data and Strategic Initiatives Drive Buy Rating for MiNK Therapeutics

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/INKT/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"INKT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INKT\",,,,,undefined,":{"symbol":"INKT","market":"US","secType":"STK","nameCN":"MiNK Therapeutics, Inc.","latestPrice":23.11,"timestamp":1752696000000,"preClose":28.01,"halted":0,"volume":883530,"hourTrading":{"tag":"盘后","latestPrice":24.4,"preClose":23.11,"latestTime":"19:29 EDT","volume":8812,"amount":210925.767964,"timestamp":1752708545648},"delay":0,"floatShares":1016778,"shares":3985657,"eps":-2.497936,"marketStatus":"Post-Mkt","change":-4.9,"latestTime":"07-16 19:30:45 EDT","open":28.43,"high":30.64,"low":23.11,"amount":23834462.22612,"amplitude":0.268833,"askPrice":24.6,"askSize":50,"bidPrice":24.13,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-2.497936,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1752710400000},"marketStatusCode":4,"adr":0,"listingDate":1634270400000,"exchange":"NASDAQ","adjPreClose":28.01,"preHourTrading":{"tag":"盘前","latestPrice":28.48,"preClose":28.01,"latestTime":"09:29 EDT","volume":10639,"amount":295491.447957,"timestamp":1752672598346},"postHourTrading":{"tag":"盘后","latestPrice":24.4,"preClose":23.11,"latestTime":"19:29 EDT","volume":8812,"amount":210925.767964,"timestamp":1752708545648},"volumeRatio":0.081219},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"INKT\",,,,,undefined,":{"symbol":"INKT","floatShares":1016778,"roa":"-111.90%","roe":"-1238.98%","lyrEps":-2.858168,"volumeRatio":0.081219,"shares":3985657,"dividePrice":0,"high":30.64,"amplitude":0.268833,"preClose":28.01,"low":23.11,"week52Low":4.5601,"pbRate":"-4.23","week52High":76,"institutionHeld":0,"latestPrice":23.11,"committee":0.333333,"eps":-2.497936,"divideRate":0,"volume":883530,"delay":0,"ttmEps":-2.497936,"open":28.43,"prevYearClose":6.969,"prevWeekClose":64.17,"prevMonthClose":7.3876,"prevQuarterClose":7.3876,"fiveDayClose":7.2816,"twentyDayClose":7.5729,"sixtyDayClose":7.25},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"INKT\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2550958318","title":"BRIEF-Mink Therapeutics Announces Publication Of Complete Remission","url":"https://stock-news.laohu8.com/highlight/detail?id=2550958318","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550958318?lang=en_us&edition=fundamental","pubTime":"2025-07-11 19:33","pubTimestamp":1752233586,"startTime":"0","endTime":"0","summary":"BRIEF-Mink Therapeutics Announces Publication Of Complete Remission July 11 (Reuters) - Mink Therapeutics Inc INKT.O:MINK THERAPEUTICS ANNOUNCES PUBLICATION OF COMPLETE REMISSION FOLLOWING ALLOGENEIC ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250711:nFWN3T804Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INKT"],"gpt_icon":0},{"id":"2550958353","title":"Mink Therapeutics Announces Promising Results of Allogeneic iNKT Cell Therapy, Achieving Complete Remission in Metastatic Testicular Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2550958353","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550958353?lang=en_us&edition=fundamental","pubTime":"2025-07-11 19:30","pubTimestamp":1752233416,"startTime":"0","endTime":"0","summary":"Mink Therapeutics Announces Promising Results of Allogeneic iNKT Cell Therapy, Achieving Complete Remission in Metastatic Testicular Cancer. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mink Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on July 11, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250711:nNDLBQplD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU2095319765.USD","BK4588","IE00BGHQF748.EUR","LU2210149790.SGD","IE00BKPKM429.USD","INKT","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","LU2210150020.SGD","NDAQ","BK4585","BK4112"],"gpt_icon":0},{"id":"2550958386","title":"Mink Therapeutics Announces Publication of Complete Remission Following Allogeneic Inkt Cell Therapy in Metastatic Testicular Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2550958386","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550958386?lang=en_us&edition=fundamental","pubTime":"2025-07-11 19:30","pubTimestamp":1752233414,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250711:nFWN3T804Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INKT","BK4139"],"gpt_icon":0},{"id":"2544217188","title":"MiNK Therapeutics Holds Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2544217188","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544217188?lang=en_us&edition=fundamental","pubTime":"2025-06-19 04:31","pubTimestamp":1750278669,"startTime":"0","endTime":"0","summary":"MiNK Therapeutics ( ($INKT) ) has shared an update. MiNK Therapeutics held its Annual Meeting of Stockholders on June 18, 2025, where 70.41% of eli...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mink-therapeutics-holds-annual-stockholders-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mink-therapeutics-holds-annual-stockholders-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","LENZ","BK4007","INKT"],"gpt_icon":0},{"id":"2544590074","title":"Mink Therapeutics Inc. Conducted Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2544590074","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544590074?lang=en_us&edition=fundamental","pubTime":"2025-06-19 04:10","pubTimestamp":1750277457,"startTime":"0","endTime":"0","summary":"Mink Therapeutics Inc. held its Annual Meeting of Stockholders on June 18, 2025. During the meeting, stockholders voted on several proposals. Jennifer Buell and Ulf Wiinberg were elected as Class I directors. The option exchange proposal was approved. Additionally, the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mink Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 18, 2025, and is solely responsible for the information contained","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250618:nNDL9sCxCJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","INKT"],"gpt_icon":0},{"id":"2542534112","title":"Press Release: MiNK Therapeutics Announces Virtual Annual Shareholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2542534112","media":"Dow Jones","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542534112?lang=en_us&edition=fundamental","pubTime":"2025-06-11 01:33","pubTimestamp":1749576780,"startTime":"0","endTime":"0","summary":"NEW YORK, June 10, 2025  -- MiNK Therapeutics, Inc. , a clinical-stage biopharmaceutical company pioneering allogeneic, off-the-shelf invariant natural killer T  cell therapies, today announced that its Annual Shareholders Meeting will begin at 9:30 a.m. ET. on June 18, 2025, and will be conducted in a virtual format only. Registration for attendees will start at 9:15 a.m. ET.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4139","BK4007","BK4539","INKT"],"gpt_icon":0},{"id":"2540279556","title":"MiNK Therapeutics Secures NIAID Grant to Advance Allo-iNKT Cell Therapy for GvHD Prevention in Collaboration with University of Wisconsin","url":"https://stock-news.laohu8.com/highlight/detail?id=2540279556","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540279556?lang=en_us&edition=fundamental","pubTime":"2025-06-02 21:29","pubTimestamp":1748870948,"startTime":"0","endTime":"0","summary":"MiNK Therapeutics Secures NIAID Grant to Advance Allo-iNKT Cell Therapy for GvHD Prevention in Collaboration with University of Wisconsin. MiNK Therapeutics Inc., a clinical-stage biopharmaceutical company, has been awarded a prestigious grant from the National Institute of Allergy and Infectious Diseases , a part of the National Institutes of Health . This non-dilutive funding will support the development of MiNK's allogeneic invariant natural killer T  cell therapy platform, aimed at preventing and treating graft-versus-host disease  following hematopoietic stem cell transplantation . The grant is a collaborative effort with the University of Wisconsin, highlighting the partnership between MiNK's iNKT manufacturing capabilities and the university's expertise in transplant immunology. This funding underscores the promise of iNKT cells in immune regulation and accelerates the development of therapies for a significant unmet medical need.Disclaimer: This news brief was created by Public","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nNDLbGmNbK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","BK4585","LU2095319765.USD","IE00B64PRP62.GBP","NDAQ","IE00B3QW5Z07.USD","IE00BKPKM429.USD","BK4588","LU2210149790.SGD","INKT","BK4112","BK4139","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2540795324","title":"Mink Therapeutics Awarded Prestigious Niaid Grant to Advance Allo-Inkt Cell Therapy for Prevention of Gvhd in Stem Cell Transplant Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2540795324","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540795324?lang=en_us&edition=fundamental","pubTime":"2025-06-02 21:29","pubTimestamp":1748870940,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nTUA926JQW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INKT"],"gpt_icon":0},{"id":"2535822855","title":"MiNK Therapeutics: Promising Clinical Trials and Strategic Plans Justify Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2535822855","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535822855?lang=en_us&edition=fundamental","pubTime":"2025-05-15 22:35","pubTimestamp":1747319719,"startTime":"0","endTime":"0","summary":"In a report released today, Emily Bodnar from H.C. Wainwright maintained a Buy rating on MiNK Therapeutics (INKT – Research Report), with a price t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/mink-therapeutics-promising-clinical-trials-and-strategic-plans-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/mink-therapeutics-promising-clinical-trials-and-strategic-plans-justify-buy-rating?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INKT","LENZ"],"gpt_icon":0},{"id":"2535582687","title":"Mink Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2535582687","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535582687?lang=en_us&edition=fundamental","pubTime":"2025-05-15 21:32","pubTimestamp":1747315962,"startTime":"0","endTime":"0","summary":"Mink Therapeutics Inc reports results for the quarter ended March 31 - Earnings SummaryMink Therapeutics Inc INKT.OQ reported a quarterly adjusted loss of 70 cents per share for the quarter ended Marc","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nL8N3RN1NZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INKT"],"gpt_icon":0},{"id":"2535849067","title":"MiNK Therapeutics Q1 EPS $(0.70) Beats $(0.71) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2535849067","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535849067?lang=en_us&edition=fundamental","pubTime":"2025-05-15 19:31","pubTimestamp":1747308697,"startTime":"0","endTime":"0","summary":"MiNK Therapeutics Q1 EPS $(0.70) Beats $(0.71) Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45433434/mink-therapeutics-q1-eps-0-70-beats-0-71-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","INKT"],"gpt_icon":0},{"id":"2535849052","title":"MiNK Therapeutics Reports Q1 2025 Results: Net Loss Decreases to $2.8 Million, EPS Improves to $(0.70)","url":"https://stock-news.laohu8.com/highlight/detail?id=2535849052","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535849052?lang=en_us&edition=fundamental","pubTime":"2025-05-15 19:30","pubTimestamp":1747308621,"startTime":"0","endTime":"0","summary":"MiNK Therapeutics Inc. has announced its financial results for the first quarter of 2025. The company reported a net loss of $2.8 million for this period, which marks an improvement from the $3.8 million net loss recorded in the first quarter of 2024. The net loss per share was $0.70 compared to $1.10 in the same period last year. MiNK ended the quarter with a cash balance of $3.2 million, and cash used in operations was $1.3 million, down from $2.5 million in the corresponding period of 2024. In its business operations, MiNK highlighted clinical progress with complete response data in testicular cancer, ongoing enrollment in a Phase 2 gastric trial, and new data emerging in PD-1-resistant tumors. Additionally, MiNK is poised to receive probable funding from NIAID by June 2025 to support its allogeneic iNKT program in GvHD, signaling recognition of its leadership in inflammation and immune modulation. These developments are seen as expansion opportunities within MiNK's core verticals, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nNDL8GwxbC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","INKT"],"gpt_icon":0},{"id":"2535849740","title":"Mink Therapeutics Reports Q1 2025 Results and Highlights Clinical & Strategic Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2535849740","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535849740?lang=en_us&edition=fundamental","pubTime":"2025-05-15 19:30","pubTimestamp":1747308601,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nTUA1TJTXG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","INKT"],"gpt_icon":0},{"id":"2535849019","title":"Press Release: MiNK Therapeutics Reports Q1 2025 Results and Highlights Clinical & Strategic Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2535849019","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535849019?lang=en_us&edition=fundamental","pubTime":"2025-05-15 19:30","pubTimestamp":1747308600,"startTime":"0","endTime":"0","summary":"-- Clinical data builds with CR in testicular cancer, enrollment in Phase 2. gastric trial, and new data in PD-1--resistant tumors. -- Near-term capital transactions poised to bolster liquidity. NEW YORK, May 15, 2025  -- MiNK Therapeutics, Inc. , a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf invariant natural killer T  cell therapies, today announced its financial results for the first quarter of 2025 and provided a business update highlighting continued clinical progress and strategic developments across its iNKT platform. The company will host a conference call and webcast today at 8:30 a.m. ET.\"This quarter marks a turning point in the evolution of MiNK. Our platform is demonstrating the power of iNKT cells to transform immune responses in both cancer and inflammatory diseases,\" said Jennifer Buell, Ph.D., President and Chief Executive Officer of MiNK Therapeutics. \"With late-stage strategic discussions underway across oncology, ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","INKT","BK4139","BK4007","LU2065732104.USD","LENZ","PRGS","BK4097"],"gpt_icon":0},{"id":"2533505555","title":"MiNK Therapeutics to Provide Corporate Update and First Quarter 2025 Financial Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2533505555","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533505555?lang=en_us&edition=fundamental","pubTime":"2025-05-06 00:30","pubTimestamp":1746462600,"startTime":"0","endTime":"0","summary":"NEW YORK, May 05, 2025  -- MiNK Therapeutics, Inc. , a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T  cell therapies to treat cancer and other immune-mediated diseases, today announced that the Company will release its first quarter 2025 financial results before the market opens on Thursday, May 15th. MiNK executives will host a conference call and webcast at 8:30 a.m. ET that morning to discuss the results and provide a corporate update.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mink-therapeutics-corporate-first-quarter-163000844.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LENZ","BK4139","INKT","BK4007"],"gpt_icon":0},{"id":"2520949172","title":"MiNK Therapeutics Inc (INKT) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2520949172","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520949172?lang=en_us&edition=fundamental","pubTime":"2025-03-19 15:01","pubTimestamp":1742367712,"startTime":"0","endTime":"0","summary":"Cash Used in Operations: $1.7 million for Q4 2024; $9.6 million for the full year 2024.Net Loss: $10.8 million for 2024, or $2.86 per share.Net Loss Comparison: $22.5 million for 2023, or $6.54 per share.For the complete transcript of the earnings call, please refer to the full earnings call transcript.MiNK Therapeutics Inc  strengthened its leadership team by adding Dr. Robert Kadlec, a renowned leader in biodefense and pandemic preparedness, to its Board of Directors.The company expanded its innovation toolkit through a strategic collaboration with Autonomous Therapeutics, aiming to enhance its iNKT cell therapies with encrypted RNA technology.Also, what are the main focuses for 2025 regarding 797 in gastric cancer and GVHD?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mink-therapeutics-inc-inkt-q4-070152016.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["INKT"],"gpt_icon":0},{"id":"2520748990","title":"MiNK Therapeutics Reports 2024 Progress and Financials","url":"https://stock-news.laohu8.com/highlight/detail?id=2520748990","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520748990?lang=en_us&edition=fundamental","pubTime":"2025-03-19 11:54","pubTimestamp":1742356470,"startTime":"0","endTime":"0","summary":"Mink Therapeutics, Inc. ( ($INKT) ) has released its Q4 earnings. Here is a breakdown of the information Mink Therapeutics, Inc. presented to its i...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mink-therapeutics-reports-2024-progress-and-financials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mink-therapeutics-reports-2024-progress-and-financials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRGS","BK4097","LENZ","LU2065732104.USD","BK4139","INKT"],"gpt_icon":0},{"id":"2520924019","title":"Q4 2024 Mink Therapeutics Inc Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2520924019","media":"Thomson Reuters StreetEvents","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520924019?lang=en_us&edition=fundamental","pubTime":"2025-03-19 11:42","pubTimestamp":1742355749,"startTime":"0","endTime":"0","summary":"Jennifer Buell; President, Chief Executive Officer, Director; Mink Therapeutics Inc. Jack Allen; Analyst; Robert W. Baird & Co., Inc.Hello, everyone, and welcome to MiNK Therapeutics fourth-quarter 2024 financial results call. Please note that this call is being recorded.  I'd now like to hand the call over to Zach Armen, Investor Relations. You may now begin.Thank you, operator, and thank you all for joining us today. Today's call is being webcast and will be available on our website for replay. I'd like to remind you that this call will include forward-looking statements, including those related to our clinical development, regulatory and commercial plans, timelines for data release and partnership opportunities. These statements are subject to risk and uncertainty. Please refer to our SEC filings available on our website for a detailed description of these risks. Joining me today are Doctor Jennifer Buell, President and Chief Executive Officer, and Christine Klaskin, Principal Finan","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/q4-2024-mink-therapeutics-inc-034229365.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["INKT","LENZ"],"gpt_icon":0},{"id":"2520554809","title":"Buy Rating Affirmed for MiNK Therapeutics Amid Promising Clinical Developments and Strategic Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2520554809","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520554809?lang=en_us&edition=fundamental","pubTime":"2025-03-19 05:55","pubTimestamp":1742334910,"startTime":"0","endTime":"0","summary":"William Blair analyst Matt Phipps has maintained their bullish stance on INKT stock, giving a Buy rating today. Matt Phipps has given his Buy ratin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-affirmed-for-mink-therapeutics-amid-promising-clinical-developments-and-strategic-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-affirmed-for-mink-therapeutics-amid-promising-clinical-developments-and-strategic-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INKT","LENZ"],"gpt_icon":0},{"id":"2520216609","title":"Promising Clinical Data and Strategic Initiatives Drive Buy Rating for MiNK Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2520216609","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520216609?lang=en_us&edition=fundamental","pubTime":"2025-03-18 22:25","pubTimestamp":1742307908,"startTime":"0","endTime":"0","summary":"Analyst Emily Bodnar of H.C. Wainwright maintained a Buy rating on MiNK Therapeutics (INKT – Research Report), retaining the price target of $35.00...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-clinical-data-and-strategic-initiatives-drive-buy-rating-for-mink-therapeutics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-clinical-data-and-strategic-initiatives-drive-buy-rating-for-mink-therapeutics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["INKT","LENZ"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":55,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/INKT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-15","symbol":"INKT","fiscalQuarterEnding":"2025/03","expectedEps":-0.61,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":-0.7},{"market":"US","date":"2025-03-18","symbol":"INKT","fiscalQuarterEnding":"2024/12","expectedEps":-0.5,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742270400000,"reportTimeType":"pre","actualEps":-0.62},{"market":"US","date":"2025-01-28","symbol":"INKT","defaultRemindTime":1738074600000,"type":"split","dateTimestamp":1738040400000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"US","date":"2024-11-14","symbol":"INKT","fiscalQuarterEnding":"2024/09","expectedEps":-0.08,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"pre","actualEps":-0.05},{"market":"US","date":"2024-08-13","symbol":"INKT","fiscalQuarterEnding":"2024/06","expectedEps":-0.1,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"pre","actualEps":-0.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"INKT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"INKT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.6667,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1752292800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/INKT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"INKT","date":"2025-07-15","current":-16.620881,"percent":0.037322,"low":-37.223699,"twenty":-3.151841,"median":-2.497611,"eighty":-1.618866,"high":-1.078214,"avg":-3.542634,"sd":5.356847,"marketCap":161857530},"quantilePoints":[{"date":"2021-10-15","current":-22.300768,"twenty":-24.056031,"median":-24.056031,"eighty":-23.002873,"marketCap":396052188},{"date":"2021-10-22","current":-22.375104,"twenty":-23.792508,"median":-22.598112,"eighty":-22.330502,"marketCap":397372361},{"date":"2021-10-29","current":-33.246729,"twenty":-24.742333,"median":-23.118463,"eighty":-22.330502,"marketCap":590447803},{"date":"2021-11-05","current":-32.298946,"twenty":-34.406369,"median":-24.056031,"eighty":-22.419706,"marketCap":573615585},{"date":"2021-11-12","current":-30.477717,"twenty":-35.268665,"median":-26.965346,"eighty":-22.575811,"marketCap":541271323},{"date":"2021-11-19","current":-29.69719,"twenty":-35.220347,"median":-29.901613,"eighty":-22.873155,"marketCap":527409497},{"date":"2021-11-26","current":-37.186531,"twenty":-35.22778,"median":-30.91444,"eighty":-23.174215,"marketCap":660417023},{"date":"2021-12-03","current":-13.513422,"twenty":-35.194329,"median":-29.734358,"eighty":-22.315635,"marketCap":351125588},{"date":"2021-12-10","current":-7.891426,"twenty":-35.116276,"median":-26.082607,"eighty":-15.473385,"marketCap":205046622},{"date":"2021-12-17","current":-5.505946,"twenty":-34.540173,"median":-24.056031,"eighty":-10.511586,"marketCap":143063574},{"date":"2021-12-23","current":-6.03462,"twenty":-33.246729,"median":-23.118463,"eighty":-8.665095,"marketCap":156800358},{"date":"2021-12-31","current":-5.750941,"twenty":-32.391866,"median":-22.430856,"eighty":-6.614872,"marketCap":149429401},{"date":"2022-01-07","current":-5.1449,"twenty":-32.298946,"median":-22.282184,"eighty":-5.738047,"marketCap":133682356},{"date":"2022-01-14","current":-4.087552,"twenty":-31.574171,"median":-16.09232,"eighty":-5.544629,"marketCap":106208789},{"date":"2022-01-21","current":-4.02308,"twenty":-31.470101,"median":-14.345117,"eighty":-5.418263,"marketCap":104533572},{"date":"2022-01-28","current":-3.726507,"twenty":-31.369747,"median":-9.761127,"eighty":-5.175847,"marketCap":96827571},{"date":"2022-02-04","current":-4.13913,"twenty":-30.652406,"median":-8.748909,"eighty":-4.652331,"marketCap":107548963},{"date":"2022-02-11","current":-3.597562,"twenty":-30.150639,"median":-6.963023,"eighty":-4.237128,"marketCap":93477136},{"date":"2022-02-18","current":-3.210727,"twenty":-29.80126,"median":-6.369877,"eighty":-4.123657,"marketCap":83425831},{"date":"2022-02-25","current":-3.339672,"twenty":-29.712057,"median":-5.892781,"eighty":-4.061763,"marketCap":86776266},{"date":"2022-03-04","current":-3.752296,"twenty":-28.058084,"median":-5.725152,"eighty":-3.899293,"marketCap":97497658},{"date":"2022-03-11","current":-2.952837,"twenty":-25.906059,"median":-5.557524,"eighty":-3.780663,"marketCap":76724961},{"date":"2022-03-18","current":-3.487668,"twenty":-24.513566,"median":-5.505946,"eighty":-3.726507,"marketCap":105372120},{"date":"2022-03-25","current":-2.72127,"twenty":-24.056031,"median":-5.35766,"eighty":-3.669771,"marketCap":82217100},{"date":"2022-04-01","current":-2.610198,"twenty":-23.660746,"median":-5.183584,"eighty":-3.582088,"marketCap":78861300},{"date":"2022-04-08","current":-3.054487,"twenty":-23.229967,"median":-4.874116,"eighty":-3.378356,"marketCap":92284500},{"date":"2022-04-14","current":-3.254417,"twenty":-22.954924,"median":-4.648462,"eighty":-3.355146,"marketCap":98324940},{"date":"2022-04-22","current":-2.543554,"twenty":-22.620413,"median":-4.332548,"eighty":-3.278852,"marketCap":76847820},{"date":"2022-04-29","current":-2.488018,"twenty":-22.442006,"median":-4.177814,"eighty":-3.202991,"marketCap":75169920},{"date":"2022-05-06","current":-2.165909,"twenty":-22.34537,"median":-4.126236,"eighty":-3.091194,"marketCap":65438100},{"date":"2022-05-13","current":-2.747969,"twenty":-22.293334,"median":-4.087552,"eighty":-2.86808,"marketCap":43293579},{"date":"2022-05-20","current":-2.790574,"twenty":-22.06661,"median":-4.010185,"eighty":-2.747969,"marketCap":43964797},{"date":"2022-05-27","current":-3.557449,"twenty":-19.895501,"median":-3.965054,"eighty":-2.747969,"marketCap":56046726},{"date":"2022-06-03","current":-3.514845,"twenty":-16.711255,"median":-3.829663,"eighty":-2.752229,"marketCap":55375508},{"date":"2022-06-10","current":-3.47224,"twenty":-15.04013,"median":-3.803874,"eighty":-2.773532,"marketCap":54704289},{"date":"2022-06-17","current":-3.429636,"twenty":-14.71261,"median":-3.797427,"eighty":-2.790574,"marketCap":54033071},{"date":"2022-06-24","current":-3.216615,"twenty":-13.732629,"median":-3.778085,"eighty":-2.790574,"marketCap":50676980},{"date":"2022-07-01","current":-2.982292,"twenty":-13.513422,"median":-3.726507,"eighty":-2.811876,"marketCap":46985279},{"date":"2022-07-08","current":-2.811876,"twenty":-10.511586,"median":-3.713612,"eighty":-2.811876,"marketCap":44300406},{"date":"2022-07-15","current":-2.705365,"twenty":-9.224716,"median":-3.680095,"eighty":-2.765011,"marketCap":42622360},{"date":"2022-07-22","current":-2.939688,"twenty":-8.884301,"median":-3.636245,"eighty":-2.786313,"marketCap":46314061},{"date":"2022-07-29","current":-2.790574,"twenty":-8.698621,"median":-3.603705,"eighty":-2.790574,"marketCap":43964797},{"date":"2022-08-05","current":-2.875782,"twenty":-8.04616,"median":-3.557449,"eighty":-2.786313,"marketCap":45307233},{"date":"2022-08-12","current":-1.691835,"twenty":-7.148704,"median":-3.523471,"eighty":-2.747969,"marketCap":57389162},{"date":"2022-08-19","current":-2.588795,"twenty":-6.901129,"median":-3.487668,"eighty":-2.747969,"marketCap":87815189},{"date":"2022-08-26","current":-2.339873,"twenty":-6.669029,"median":-3.423337,"eighty":-2.740426,"marketCap":79371421},{"date":"2022-09-02","current":-2.568881,"twenty":-6.222879,"median":-3.378356,"eighty":-2.707695,"marketCap":87139688},{"date":"2022-09-09","current":-2.777976,"twenty":-6.070724,"median":-3.339672,"eighty":-2.698398,"marketCap":94232453},{"date":"2022-09-16","current":-2.389657,"twenty":-5.864413,"median":-3.318504,"eighty":-2.666174,"marketCap":81060175},{"date":"2022-09-23","current":-1.96151,"twenty":-5.743205,"median":-3.298845,"eighty":-2.620846,"marketCap":66536893},{"date":"2022-09-30","current":-2.100907,"twenty":-5.73031,"median":-3.280522,"eighty":-2.609602,"marketCap":71265404},{"date":"2022-10-07","current":-2.180562,"twenty":-5.686469,"median":-3.259219,"eighty":-2.58847,"marketCap":73967409},{"date":"2022-10-14","current":-1.881855,"twenty":-5.606523,"median":-3.234098,"eighty":-2.550218,"marketCap":63834887},{"date":"2022-10-21","current":-1.971467,"twenty":-5.554945,"median":-3.216615,"eighty":-2.520619,"marketCap":66874644},{"date":"2022-10-28","current":-2.021252,"twenty":-5.529156,"median":-3.196573,"eighty":-2.483575,"marketCap":68563398},{"date":"2022-11-04","current":-3.172412,"twenty":-5.511104,"median":-3.174011,"eighty":-2.476911,"marketCap":82437666},{"date":"2022-11-11","current":-3.900507,"twenty":-5.459526,"median":-3.185989,"eighty":-2.476911,"marketCap":101357787},{"date":"2022-11-18","current":-3.458449,"twenty":-5.397632,"median":-3.210727,"eighty":-2.483575,"marketCap":89870571},{"date":"2022-11-25","current":-3.341434,"twenty":-5.361528,"median":-3.216615,"eighty":-2.488018,"marketCap":86829837},{"date":"2022-12-02","current":-3.276425,"twenty":-5.328002,"median":-3.243208,"eighty":-2.488018,"marketCap":85140541},{"date":"2022-12-09","current":-3.256923,"twenty":-5.260951,"median":-3.250422,"eighty":-2.492461,"marketCap":84633752},{"date":"2022-12-16","current":-2.951383,"twenty":-5.16811,"median":-3.250422,"eighty":-2.513454,"marketCap":76694058},{"date":"2022-12-23","current":-3.016392,"twenty":-5.108796,"median":-3.232202,"eighty":-2.534948,"marketCap":78383355},{"date":"2022-12-30","current":-3.393441,"twenty":-4.98243,"median":-3.216615,"eighty":-2.536669,"marketCap":88181274},{"date":"2023-01-06","current":-3.07958,"twenty":-4.693593,"median":-3.216615,"eighty":-2.543554,"marketCap":80025351},{"date":"2023-01-13","current":-3.068398,"twenty":-4.65491,"median":-3.196573,"eighty":-2.543554,"marketCap":79734792},{"date":"2023-01-20","current":-2.964385,"twenty":-4.644594,"median":-3.175339,"eighty":-2.55244,"marketCap":77031918},{"date":"2023-01-27","current":-2.912378,"twenty":-4.6317,"median":-3.165559,"eighty":-2.566037,"marketCap":75680480},{"date":"2023-02-03","current":-2.886375,"twenty":-4.391863,"median":-3.100903,"eighty":-2.568881,"marketCap":75004762},{"date":"2023-02-10","current":-2.860371,"twenty":-4.308927,"median":-3.0814,"eighty":-2.584163,"marketCap":74329043},{"date":"2023-02-17","current":-2.743356,"twenty":-4.254433,"median":-3.073989,"eighty":-2.588633,"marketCap":71288310},{"date":"2023-02-24","current":-2.743356,"twenty":-4.226813,"median":-3.067501,"eighty":-2.588795,"marketCap":71288310},{"date":"2023-03-03","current":-2.788862,"twenty":-4.170077,"median":-3.024896,"eighty":-2.588795,"marketCap":72470817},{"date":"2023-03-10","current":-2.600338,"twenty":-4.131394,"median":-3.011688,"eighty":-2.595721,"marketCap":67571858},{"date":"2023-03-17","current":-2.886375,"twenty":-4.126236,"median":-3.003594,"eighty":-2.600338,"marketCap":75004762},{"date":"2023-03-24","current":-2.435067,"twenty":-4.118499,"median":-3.00339,"eighty":-2.588795,"marketCap":68160482},{"date":"2023-03-31","current":-2.295747,"twenty":-4.110457,"median":-2.990388,"eighty":-2.563815,"marketCap":64260753},{"date":"2023-04-06","current":-2.265461,"twenty":-4.100141,"median":-2.982292,"eighty":-2.543554,"marketCap":63412986},{"date":"2023-04-14","current":-2.750051,"twenty":-4.087552,"median":-2.979839,"eighty":-2.543554,"marketCap":76977261},{"date":"2023-04-21","current":-2.435067,"twenty":-4.061763,"median":-2.972836,"eighty":-2.53839,"marketCap":68160482},{"date":"2023-04-28","current":-2.277575,"twenty":-4.017922,"median":-2.958611,"eighty":-2.534948,"marketCap":63752093},{"date":"2023-05-05","current":-1.514345,"twenty":-4.005027,"median":-2.951383,"eighty":-2.488018,"marketCap":42388360},{"date":"2023-05-12","current":-1.962591,"twenty":-3.994098,"median":-2.948132,"eighty":-2.479557,"marketCap":54935314},{"date":"2023-05-19","current":-2.285931,"twenty":-3.987343,"median":-2.939688,"eighty":-2.4702,"marketCap":59205948},{"date":"2023-05-26","current":-2.578317,"twenty":-3.984034,"median":-2.921883,"eighty":-2.4702,"marketCap":66778802},{"date":"2023-06-02","current":-2.392253,"twenty":-3.975935,"median":-2.912378,"eighty":-2.469312,"marketCap":61959713},{"date":"2023-06-09","current":-2.977026,"twenty":-3.940487,"median":-2.912378,"eighty":-2.466506,"marketCap":77105421},{"date":"2023-06-16","current":-3.189671,"twenty":-3.915769,"median":-2.912378,"eighty":-2.469312,"marketCap":82612951},{"date":"2023-06-23","current":-4.419023,"twenty":-3.919584,"median":-2.921883,"eighty":-2.469312,"marketCap":114453359},{"date":"2023-06-30","current":-2.777671,"twenty":-3.904322,"median":-2.926214,"eighty":-2.471089,"marketCap":71942111},{"date":"2023-07-06","current":-2.658059,"twenty":-3.886829,"median":-2.918386,"eighty":-2.473684,"marketCap":68844126},{"date":"2023-07-14","current":-2.471995,"twenty":-3.851652,"median":-2.909897,"eighty":-2.473961,"marketCap":64025037},{"date":"2023-07-21","current":-2.445414,"twenty":-3.829663,"median":-2.897284,"eighty":-2.471718,"marketCap":63336595},{"date":"2023-07-28","current":-2.219479,"twenty":-3.819347,"median":-2.892724,"eighty":-2.464872,"marketCap":57484845},{"date":"2023-08-04","current":-2.285931,"twenty":-3.803522,"median":-2.886375,"eighty":-2.444319,"marketCap":59205948},{"date":"2023-08-11","current":-2.551736,"twenty":-3.798505,"median":-2.873373,"eighty":-2.438476,"marketCap":66090360},{"date":"2023-08-18","current":-2.217831,"twenty":-3.791455,"median":-2.870703,"eighty":-2.432124,"marketCap":57628921},{"date":"2023-08-25","current":-2.071746,"twenty":-3.780663,"median":-2.857464,"eighty":-2.423268,"marketCap":53833004},{"date":"2023-09-01","current":-1.925661,"twenty":-3.762611,"median":-2.85448,"eighty":-2.404114,"marketCap":50037087},{"date":"2023-09-07","current":-1.938942,"twenty":-3.757454,"median":-2.85448,"eighty":-2.396135,"marketCap":50382170},{"date":"2023-09-15","current":-1.673333,"twenty":-3.736823,"median":-2.84737,"eighty":-2.386511,"marketCap":43480503},{"date":"2023-09-21","current":-1.766296,"twenty":-3.726507,"median":-2.834368,"eighty":-2.339404,"marketCap":45896086},{"date":"2023-09-29","current":-1.673333,"twenty":-3.721349,"median":-2.827272,"eighty":-2.318672,"marketCap":43480503},{"date":"2023-10-06","current":-1.527249,"twenty":-3.708454,"median":-2.811876,"eighty":-2.300255,"marketCap":39684586},{"date":"2023-10-13","current":-1.513968,"twenty":-3.694535,"median":-2.795363,"eighty":-2.295747,"marketCap":39339503},{"date":"2023-10-20","current":-1.394444,"twenty":-3.681128,"median":-2.795363,"eighty":-2.285931,"marketCap":36233752},{"date":"2023-10-27","current":-1.208518,"twenty":-3.676995,"median":-2.795363,"eighty":-2.279759,"marketCap":31402585},{"date":"2023-11-03","current":-1.367884,"twenty":-3.664613,"median":-2.790574,"eighty":-2.259014,"marketCap":35543586},{"date":"2023-11-10","current":-1.474127,"twenty":-3.641403,"median":-2.777976,"eighty":-2.229732,"marketCap":38304252},{"date":"2023-11-17","current":-1.375696,"twenty":-3.636245,"median":-2.773515,"eighty":-2.215242,"marketCap":34073530},{"date":"2023-11-24","current":-1.421532,"twenty":-3.631448,"median":-2.769315,"eighty":-2.196794,"marketCap":35209930},{"date":"2023-12-01","current":-1.463342,"twenty":-3.620276,"median":-2.750051,"eighty":-2.167489,"marketCap":36245517},{"date":"2023-12-08","current":-1.421532,"twenty":-3.61496,"median":-2.748037,"eighty":-2.120821,"marketCap":35209930},{"date":"2023-12-15","current":-1.505152,"twenty":-3.611893,"median":-2.747969,"eighty":-2.096924,"marketCap":37281103},{"date":"2023-12-22","current":-1.407596,"twenty":-3.602476,"median":-2.74342,"eighty":-2.061079,"marketCap":34864735},{"date":"2023-12-29","current":-1.533025,"twenty":-3.589825,"median":-2.743356,"eighty":-2.053113,"marketCap":37971494},{"date":"2024-01-05","current":-1.560898,"twenty":-3.566615,"median":-2.740578,"eighty":-2.045153,"marketCap":38661884},{"date":"2024-01-12","current":-1.365786,"twenty":-3.557735,"median":-2.730355,"eighty":-2.017158,"marketCap":33829149},{"date":"2024-01-19","current":-1.205794,"twenty":-3.544668,"median":-2.72127,"eighty":-1.987398,"marketCap":29866306},{"date":"2024-01-26","current":-1.198547,"twenty":-3.533717,"median":-2.712816,"eighty":-1.962159,"marketCap":29686804},{"date":"2024-02-02","current":-1.252899,"twenty":-3.521746,"median":-2.704351,"eighty":-1.940534,"marketCap":31033066},{"date":"2024-02-09","current":-1.198686,"twenty":-3.514845,"median":-2.684639,"eighty":-1.909187,"marketCap":29690256},{"date":"2024-02-16","current":-1.296103,"twenty":-3.498539,"median":-2.684063,"eighty":-1.809428,"marketCap":32103172},{"date":"2024-02-23","current":-1.292201,"twenty":-3.481497,"median":-2.677362,"eighty":-1.758328,"marketCap":32006517},{"date":"2024-03-01","current":-1.283978,"twenty":-3.466724,"median":-2.665605,"eighty":-1.713175,"marketCap":31802852},{"date":"2024-03-08","current":-1.297496,"twenty":-3.453248,"median":-2.658059,"eighty":-1.673333,"marketCap":32137691},{"date":"2024-03-15","current":-1.240356,"twenty":-3.439123,"median":-2.655201,"eighty":-1.625524,"marketCap":30722390},{"date":"2024-03-22","current":-1.240356,"twenty":-3.424597,"median":-2.639343,"eighty":-1.572402,"marketCap":30722390},{"date":"2024-03-28","current":-1.406017,"twenty":-3.414868,"median":-2.622846,"eighty":-1.553809,"marketCap":31576140},{"date":"2024-04-05","current":-2.070399,"twenty":-3.405409,"median":-2.619412,"eighty":-1.533025,"marketCap":46496735},{"date":"2024-04-12","current":-1.575976,"twenty":-3.40054,"median":-2.613469,"eighty":-1.535435,"marketCap":35393037},{"date":"2024-04-19","current":-1.346841,"twenty":-3.391822,"median":-2.611769,"eighty":-1.524363,"marketCap":30247167},{"date":"2024-04-26","current":-1.346069,"twenty":-3.384366,"median":-2.608709,"eighty":-1.514043,"marketCap":30229817},{"date":"2024-05-03","current":-1.498008,"twenty":-3.380022,"median":-2.600403,"eighty":-1.501581,"marketCap":33642042},{"date":"2024-05-10","current":-1.389682,"twenty":-3.378356,"median":-2.588795,"eighty":-1.491335,"marketCap":31209292},{"date":"2024-05-17","current":-1.753313,"twenty":-3.373572,"median":-2.588389,"eighty":-1.491335,"marketCap":36092143},{"date":"2024-05-24","current":-1.66059,"twenty":-3.354436,"median":-2.568881,"eighty":-1.494743,"marketCap":34183424},{"date":"2024-05-31","current":-1.834832,"twenty":-3.354436,"median":-2.56833,"eighty":-1.498008,"marketCap":37770224},{"date":"2024-06-07","current":-1.873058,"twenty":-3.341434,"median":-2.555438,"eighty":-1.500688,"marketCap":38557104},{"date":"2024-06-14","current":-1.847027,"twenty":-3.340024,"median":-2.551736,"eighty":-1.504259,"marketCap":38021265},{"date":"2024-06-21","current":-1.664007,"twenty":-3.339672,"median":-2.551736,"eighty":-1.510442,"marketCap":34253782},{"date":"2024-06-28","current":-1.778562,"twenty":-3.339672,"median":-2.547918,"eighty":-1.513968,"marketCap":36611904},{"date":"2024-07-05","current":-1.723867,"twenty":-3.326435,"median":-2.543827,"eighty":-1.513968,"marketCap":35485989},{"date":"2024-07-12","current":-1.852765,"twenty":-3.31697,"median":-2.538446,"eighty":-1.514057,"marketCap":38139368},{"date":"2024-07-15","current":-2.141924,"twenty":-3.315431,"median":-2.536697,"eighty":-1.514079,"marketCap":44091755},{"date":"2024-08-02","current":-1.717364,"twenty":-3.315121,"median":-2.534948,"eighty":-1.514132,"marketCap":35352139},{"date":"2024-08-09","current":-1.54907,"twenty":-3.312502,"median":-2.523913,"eighty":-1.514354,"marketCap":31887787},{"date":"2024-08-16","current":-1.894958,"twenty":-3.306069,"median":-2.511866,"eighty":-1.514354,"marketCap":32384771},{"date":"2024-08-23","current":-1.868711,"twenty":-3.302308,"median":-2.493297,"eighty":-1.515328,"marketCap":31936206},{"date":"2024-08-30","current":-1.82776,"twenty":-3.301228,"median":-2.488018,"eighty":-1.519557,"marketCap":31236354},{"date":"2024-09-06","current":-1.82776,"twenty":-3.298845,"median":-2.483526,"eighty":-1.521434,"marketCap":31236354},{"date":"2024-09-13","current":-1.766912,"twenty":-3.282926,"median":-2.476911,"eighty":-1.523641,"marketCap":30196460},{"date":"2024-09-20","current":-1.774547,"twenty":-3.280522,"median":-2.471995,"eighty":-1.527249,"marketCap":30326941},{"date":"2024-09-27","current":-1.758351,"twenty":-3.280522,"median":-2.470422,"eighty":-1.527249,"marketCap":30050163},{"date":"2024-10-04","current":-1.70028,"twenty":-3.280522,"median":-2.465804,"eighty":-1.529841,"marketCap":29057717},{"date":"2024-10-11","current":-1.550126,"twenty":-3.276425,"median":-2.454052,"eighty":-1.533025,"marketCap":26491591},{"date":"2024-10-18","current":-1.55082,"twenty":-3.276425,"median":-2.443589,"eighty":-1.533025,"marketCap":26503453},{"date":"2024-10-25","current":-1.67483,"twenty":-3.265524,"median":-2.435067,"eighty":-1.538558,"marketCap":28622780},{"date":"2024-10-31","current":-1.66812,"twenty":-3.263844,"median":-2.432124,"eighty":-1.543771,"marketCap":28508115},{"date":"2024-11-08","current":-1.700974,"twenty":-3.263424,"median":-2.430317,"eighty":-1.548271,"marketCap":29069579},{"date":"2024-11-15","current":-1.735215,"twenty":-3.263424,"median":-2.420104,"eighty":-1.549915,"marketCap":29654766},{"date":"2024-11-22","current":-1.980018,"twenty":-3.26006,"median":-2.405543,"eighty":-1.550681,"marketCap":27284362},{"date":"2024-11-29","current":-2.102449,"twenty":-3.257841,"median":-2.398723,"eighty":-1.551791,"marketCap":28972373},{"date":"2024-12-06","current":-1.959088,"twenty":-3.255419,"median":-2.390955,"eighty":-1.553261,"marketCap":26996812},{"date":"2024-12-13","current":-1.808124,"twenty":-3.25202,"median":-2.386365,"eighty":-1.553809,"marketCap":24916484},{"date":"2024-12-20","current":-1.435593,"twenty":-3.250422,"median":-2.339482,"eighty":-1.551791,"marketCap":19782897},{"date":"2024-12-27","current":-1.515093,"twenty":-3.250422,"median":-2.334504,"eighty":-1.547282,"marketCap":20878431},{"date":"2025-01-03","current":-2.898739,"twenty":-3.247536,"median":-2.327858,"eighty":-1.549281,"marketCap":39945474},{"date":"2025-01-10","current":-2.23863,"twenty":-3.235994,"median":-2.334504,"eighty":-1.550126,"marketCap":30848980},{"date":"2025-01-17","current":-2.387872,"twenty":-3.232202,"median":-2.339092,"eighty":-1.55082,"marketCap":32905579},{"date":"2025-01-24","current":-2.798574,"twenty":-3.219732,"median":-2.339873,"eighty":-1.552115,"marketCap":38565180},{"date":"2025-01-31","current":-1.981478,"twenty":-3.216615,"median":-2.339482,"eighty":-1.553535,"marketCap":27305345},{"date":"2025-02-07","current":-3.192221,"twenty":-3.216615,"median":-2.365672,"eighty":-1.553809,"marketCap":43989744},{"date":"2025-02-14","current":-2.654432,"twenty":-3.216615,"median":-2.38724,"eighty":-1.553809,"marketCap":36578859},{"date":"2025-02-21","current":-2.834778,"twenty":-3.213082,"median":-2.390955,"eighty":-1.554293,"marketCap":39064081},{"date":"2025-02-28","current":-2.617046,"twenty":-3.202991,"median":-2.398723,"eighty":-1.558161,"marketCap":36063664},{"date":"2025-03-07","current":-2.346714,"twenty":-3.196321,"median":-2.395488,"eighty":-1.560749,"marketCap":32338406},{"date":"2025-03-14","current":-2.294948,"twenty":-3.193458,"median":-2.389657,"eighty":-1.564152,"marketCap":31625059},{"date":"2025-03-21","current":-3.090383,"twenty":-3.190691,"median":-2.392253,"eighty":-1.566782,"marketCap":33329166},{"date":"2025-03-28","current":-3.392734,"twenty":-3.193458,"median":-2.403757,"eighty":-1.568017,"marketCap":36589966},{"date":"2025-04-04","current":-3.218041,"twenty":-3.213082,"median":-2.414574,"eighty":-1.571411,"marketCap":34705930},{"date":"2025-04-11","current":-2.787743,"twenty":-3.202991,"median":-2.426108,"eighty":-1.57489,"marketCap":30065251},{"date":"2025-04-17","current":-2.879687,"twenty":-3.196825,"median":-2.432124,"eighty":-1.577667,"marketCap":31056849},{"date":"2025-04-25","current":-2.75832,"twenty":-3.194076,"median":-2.433596,"eighty":-1.58027,"marketCap":29747940},{"date":"2025-05-02","current":-2.721543,"twenty":-3.191201,"median":-2.435067,"eighty":-1.580778,"marketCap":29351300},{"date":"2025-05-09","current":-2.545304,"twenty":-3.184837,"median":-2.442315,"eighty":-1.584617,"marketCap":27450605},{"date":"2025-05-16","current":-2.640632,"twenty":-3.177217,"median":-2.449399,"eighty":-1.591135,"marketCap":28478694},{"date":"2025-05-23","current":-2.891668,"twenty":-3.175604,"median":-2.461477,"eighty":-1.59475,"marketCap":28161383},{"date":"2025-05-30","current":-2.848592,"twenty":-3.173691,"median":-2.467558,"eighty":-1.596495,"marketCap":27740172},{"date":"2025-06-06","current":-2.983655,"twenty":-3.171041,"median":-2.471533,"eighty":-1.597248,"marketCap":29055439},{"date":"2025-06-13","current":-3.090027,"twenty":-3.162815,"median":-2.474453,"eighty":-1.599877,"marketCap":30091311},{"date":"2025-06-20","current":-3.040954,"twenty":-3.151841,"median":-2.476911,"eighty":-1.604531,"marketCap":29613431},{"date":"2025-06-27","current":-3.04914,"twenty":-3.151841,"median":-2.483526,"eighty":-1.606931,"marketCap":29693144},{"date":"2025-07-03","current":-2.959671,"twenty":-3.147372,"median":-2.488018,"eighty":-1.607759,"marketCap":28821880},{"date":"2025-07-11","current":-3.163738,"twenty":-3.147372,"median":-2.492332,"eighty":-1.616416,"marketCap":30809128},{"date":"2025-07-15","current":-16.620881,"twenty":-3.151841,"median":-2.497611,"eighty":-1.618866,"marketCap":161857530}],"updateTime":1752680238445}}}